Bitcoin is predicted to reach $150,000 by year-end, with Strategy Chair Michael Saylor expecting it to hit $1 million in 4-8 years and eventually $20 million. Saylor cites banks like JPMorgan, Wells Fargo, and Citigroup as driving Bitcoin’s acceptance, leading to a tenfold market increase.
Saylor also sees artificial intelligence agents in finance accelerating blockchain adoption, with stablecoins becoming the preferred medium of exchange. Positive developments for Bitcoin include Trump’s strategic reserve, stablecoin legislation, and regulatory appointments favoring cryptocurrencies, boosting industry confidence.
Despite recent struggles after hitting a record $126,200, Bitcoin remains optimistic for new highs, supported by Strategy’s consistent purchases. The company recently acquired 390 BTC worth over $43 million, bringing its total to 640,808 BTC valued at nearly $71 billion.
Analysts like Bitwise’s Matt Hougan share Saylor’s bullish outlook, with short-term positivity despite recent setbacks. Trump’s tariffs on China impacted Bitcoin’s recent trading at $110,000 after reaching a high earlier. Strategy’s continued support through purchases helps maintain Bitcoin’s price stability. 1. The CDC reports that the number of COVID-19 cases in the US has surpassed 33 million, with over 600,000 deaths. The Delta variant continues to spread rapidly, prompting concerns about vaccine effectiveness and the need for booster shots.
2. A new study reveals that the Pfizer-BioNTech vaccine is 88% effective against the Delta variant after two doses. Moderna’s vaccine is also highly effective, with an 86% efficacy rate. Health officials urge Americans to get vaccinated to protect themselves and others from the virus.
3. In response to the rising number of cases, some states are reinstating mask mandates and social distancing measures. California, Nevada, and Illinois are among the states that have implemented new restrictions to curb the spread of the Delta variant.
4. Hospitals across the country are experiencing a surge in COVID-19 patients, putting a strain on healthcare systems. Some hospitals are running out of ICU beds and ventilators, leading to concerns about the ability to provide adequate care to all patients.
5. The FDA is expected to grant full approval to the Pfizer-BioNTech vaccine in the coming weeks. This move is hoped to increase vaccine uptake and boost public confidence in the safety and efficacy of the vaccine.
Read more at Yahoo Finance: Here’s Michael Saylor’s Year End Bitcoin Price Target